- Home
- AKRO vs ENIC Comparison
AKRO vs ENIC Comparison
Compare AKRO & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- ENIC
- Stock Information
- Founded
- AKRO 2017
- ENIC 2016
- Country
- AKRO United States
- ENIC Chile
- Employees
- AKRO N/A
- ENIC N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- ENIC Electric Utilities: Central
- Sector
- AKRO Health Care
- ENIC Utilities
- Exchange
- AKRO Nasdaq
- ENIC Nasdaq
- Market Cap
- AKRO 3.9B
- ENIC 4.4B
- IPO Year
- AKRO 2019
- ENIC N/A
- Fundamental
- Price
- AKRO $45.02
- ENIC $3.69
- Analyst Decision
- AKRO Strong Buy
- ENIC Hold
- Analyst Count
- AKRO 8
- ENIC 2
- Target Price
- AKRO $80.38
- ENIC $3.90
- AVG Volume (30 Days)
- AKRO 856.3K
- ENIC 431.2K
- Earning Date
- AKRO 08-08-2025
- ENIC 10-28-2025
- Dividend Yield
- AKRO N/A
- ENIC 5.19%
- EPS Growth
- AKRO N/A
- ENIC N/A
- EPS
- AKRO N/A
- ENIC 0.00
- Revenue
- AKRO N/A
- ENIC $4,040,237,917.00
- Revenue This Year
- AKRO N/A
- ENIC $111,648.61
- Revenue Next Year
- AKRO N/A
- ENIC N/A
- P/E Ratio
- AKRO N/A
- ENIC $37.40
- Revenue Growth
- AKRO N/A
- ENIC N/A
- 52 Week Low
- AKRO $21.34
- ENIC $2.51
- 52 Week High
- AKRO $58.40
- ENIC $4.05
- Technical
- Relative Strength Index (RSI)
- AKRO 38.25
- ENIC 73.49
- Support Level
- AKRO $43.08
- ENIC $3.44
- Resistance Level
- AKRO $46.18
- ENIC $3.63
- Average True Range (ATR)
- AKRO 1.62
- ENIC 0.07
- MACD
- AKRO -0.30
- ENIC 0.03
- Stochastic Oscillator
- AKRO 29.56
- ENIC 98.55
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About ENIC Enel Chile S.A. (Each representing 50 shares of)
Enel Chile SA is an electricity utility company, which through its subsidiaries and affiliates is engaged in the generation, transmission and distribution of electricity businesses in Chile. It operates through two segments including Generation Business and Distribution and Network Business. The Generation Business Segment is comprised of a group of electricity companies that own electricity generating plants, whose energy is transmitted and distributed to end customers. The Distribution and Network Reportable Segment is comprised of a group of electricity companies operating under a public utility concession.